Generics in China lead to a decline in Xarelto sales for Bayer

When Bayer reported its first quarter revenue, sales of Xarelto were down 5%, from €1.14 billion to €1.09 billion in the first quarter of 2021.

Related Keywords

,Bayer ,Xarelto ,Ohnson Amp Johnson ,Quarterly Sales ,Eylea ,Nubeqa ,Kerendia ,Fierce Pharma Homepage ,Pharma ,